Cargando…

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine

Detalles Bibliográficos
Autores principales: Ju, Bin, Zhou, Bing, Song, Shuo, Fan, Qing, Ge, Xiangyang, Wang, Haiyan, Cheng, Lin, Guo, Huimin, Shu, Dan, Liu, Lei, Zhang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882237/
https://www.ncbi.nlm.nih.gov/pubmed/35220661
http://dx.doi.org/10.1002/ctm2.732
_version_ 1784659649137475584
author Ju, Bin
Zhou, Bing
Song, Shuo
Fan, Qing
Ge, Xiangyang
Wang, Haiyan
Cheng, Lin
Guo, Huimin
Shu, Dan
Liu, Lei
Zhang, Zheng
author_facet Ju, Bin
Zhou, Bing
Song, Shuo
Fan, Qing
Ge, Xiangyang
Wang, Haiyan
Cheng, Lin
Guo, Huimin
Shu, Dan
Liu, Lei
Zhang, Zheng
author_sort Ju, Bin
collection PubMed
description
format Online
Article
Text
id pubmed-8882237
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88822372022-03-02 Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine Ju, Bin Zhou, Bing Song, Shuo Fan, Qing Ge, Xiangyang Wang, Haiyan Cheng, Lin Guo, Huimin Shu, Dan Liu, Lei Zhang, Zheng Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-02-27 /pmc/articles/PMC8882237/ /pubmed/35220661 http://dx.doi.org/10.1002/ctm2.732 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Ju, Bin
Zhou, Bing
Song, Shuo
Fan, Qing
Ge, Xiangyang
Wang, Haiyan
Cheng, Lin
Guo, Huimin
Shu, Dan
Liu, Lei
Zhang, Zheng
Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
title Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
title_full Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
title_fullStr Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
title_full_unstemmed Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
title_short Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
title_sort potent antibody immunity to sars‐cov‐2 variants elicited by a third dose of inactivated vaccine
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882237/
https://www.ncbi.nlm.nih.gov/pubmed/35220661
http://dx.doi.org/10.1002/ctm2.732
work_keys_str_mv AT jubin potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT zhoubing potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT songshuo potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT fanqing potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT gexiangyang potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT wanghaiyan potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT chenglin potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT guohuimin potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT shudan potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT liulei potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine
AT zhangzheng potentantibodyimmunitytosarscov2variantselicitedbyathirddoseofinactivatedvaccine